Andrew J. Colebatch
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- Polyomavirus and related diseases
- CAR-T cell therapy research
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 27
- Cutaneous Melanoma Detection and Management 15
- CAR-T cell therapy research 9
- Cancer Immunotherapy and Biomarkers 6
- Polyomavirus and related diseases 3
-
- Melanoma and MAPK Pathways 9
- Protein Degradation and Inhibitors 2
- Co-authors
- Richard A. Scolyer (18 shared papers)Wendy A. Cooper (5 shared papers)Alexander Dobrovic (4 shared papers)Peter M. Ferguson (8 shared papers)Ruta Gupta (4 shared papers)Elizabeth C. Paver (2 shared papers)Lyndal Anderson (1 shared paper)Trina Lum (1 shared paper)
- Journals
- Pathology (9 papers)Journal of Clinical Oncology (2 papers)Annals of Oncology (2 papers)Oncotarget (2 papers)British Journal of Cancer (1 paper)
- Partner nations
- AustraliaNetherlandsSwitzerland
In The Last Decade
Andrew J. Colebatch
33 papers receiving 823 citations
Peers
Comparison fields: 5 of 70
- Oncology 461
- Cancer Research 108
- Immunology 135
- Molecular Biology 239
- Cell Biology 56
Countries citing papers authored by Andrew J. Colebatch
This map shows the geographic impact of Andrew J. Colebatch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Colebatch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Colebatch more than expected).
Fields of papers citing papers by Andrew J. Colebatch
This network shows the impact of papers produced by Andrew J. Colebatch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Colebatch. The network helps show where Andrew J. Colebatch may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew J. Colebatch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 174 | |
| 2 | 2011 | 88 | |
| 3 | 2018 | 75 | |
| 4 | 2019 | 70 | |
| 5 | 2019 | 44 | |
| 6 | 2006 | 42 | |
| 7 | 2022 | 36 | |
| 8 | 2015 | 35 | |
| 9 | 2019 | 30 | |
| 10 | 2022 | 28 | |
| 11 | 2012 | 24 | |
| 12 | 2017 | 23 | |
| 13 | 2020 | 19 | |
| 14 | 2016 | 19 | |
| 15 | 2016 | 15 | |
| 16 | 2015 | 14 | |
| 17 | 2020 | 14 | |
| 18 | 2020 | 13 | |
| 19 | 2023 | 13 | |
| 20 | 2019 | 11 |
About Andrew J. Colebatch
Andrew J. Colebatch is a scholar working on Oncology, Molecular Biology, Immunology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 831 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (15 papers), CAR-T cell therapy research (9 papers), Melanoma and MAPK Pathways (9 papers), Cancer Genomics and Diagnostics (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (6 papers), Polyomavirus and related diseases (3 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Oncology (461 citations), Cancer Research (108 citations), Immunology (135 citations), Molecular Biology (239 citations) and Cell Biology (56 citations). Andrew J. Colebatch has collaborated with scholars based in Australia, Netherlands and Switzerland. Frequent co-authors include Richard A. Scolyer, Wendy A. Cooper, Alexander Dobrovic, Peter M. Ferguson, Ruta Gupta, Elizabeth C. Paver, Lyndal Anderson, Trina Lum, Joo‐Shik Shin and Sandra A. O’Toole. Their work appears in journals such as Pathology, Journal of Clinical Oncology, Annals of Oncology, Oncotarget and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.